Bioequivalence

Defined as relative bioavailability, bioequivalence involves comparison between test and reference drug products, where the test and reference products can vary, depending upon the comparison to be performed. Although bioavailability and bioequivalence are closely related, bioequivalence compari­sons rely on a criterion, a predetermined bioequivalence limit, and calculation of a interval for that cri­terion.

Use one of the following to add the Bioequivalence object to a Workflow:

Right-click menu for a Workflow object: New > NCA and Toolbox > Bioequivalence.
Main menu: Insert > NCA and Toolbox > Bioequivalence.
Right-click menu for a worksheet: Send To > NCA and Toolbox > Bioequivalence.

Note:To view the object in its own window, select it in the Object Browser and double-click it or press ENTER. All instructions for setting up and execution are the same whether the object is viewed in its own window or in Phoenix view.

This section contains information on the following topics:

User interface

The Bioequivalence model object is based on a mixed effects model. For more see “General linear mixed effects model”.

Main Mappings panel

Use the Main Mappings panel to identify how input variables are used in a bioequivalence model. A separate analysis is performed for each profile, or unique level of soft key(s). Required input is high­lighted orange in the interface.

None: Data types mapped to this context are not included in any analysis or output.

Sort: Categorical variable(s) identifying individual data profiles, such as subject ID and treat­ment in a crossover study. A separate analysis is done for each unique combination of sort variable values.

Subject: The subjects in a dataset.

Sequence: The order of drug administration.

Period: The washout period, or the time period between two treatments needed for drug elimination. Only applicable in a crossover study.

Formulation: The treatment and reference drug formulations used in a study.

Dependent: The dependent variables, such as drug concentration, that provides the values used to fit the model.

Classification: Classification variables or factors that are categorical independent variables, such as formulation, treatment, and gender.

Regressors: Regressor variables or covariates that are continuous independent variables, such as gender or body weight. The regressor variable can also be used to weight the data­set.

Input data considerations

Note:Be sure to finalize column names in your input data before sending the data to the Bioequivalence object. Changing names after the object is set up can cause the execution to fail.

Model tab

The Model tab allows users to specify the bioequivalence model.

Bioeq_Model_tab.png 

The Bioequivalence object automatically sets up default fixed effects, random effects, and repeated models for average bioequivalence studies depending on the type of study design: replicated cross­over, nonreplicated crossover, or parallel. For more details on the default settings, see, see “Average bioequivalence study designs”.

For more information on population and individual bioequivalence, see “Population and individual bio­equivalence”.

Fixed Effects tab

The Fixed Effects tab allows users to specify settings for study variables used in an average bioequiv­alence model. Population and individual bioequivalence models do not use fixed effects, so most options in the Fixed Effects tab are unavailable for population or individual bioequivalence models.

Bioeq_Fixed_Effects_tab.png 

Average bioequivalence

For average bioequivalence models the Model Specification field automatically displays an appropri­ate fixed effects model for the study type. Edit the model as needed.

Phoenix automatically specifies average bioequivalence models based on the study type selected and the dataset used. These default models are based on US FDA Guidance for Industry (January 2001).

See the following for details on the models used in a particular study type:

Replicated crossover designs 

Nonreplicated crossover designs 

Parallel designs 

Study variables in the Classification box and the Regressors/Covariates box can be dragged to the Model Specification field to create the model structure.

Parentheses in the model specification represent nesting of model terms.

Seq+Subject(Seq)+Period+Form is a valid use of parentheses and indicates that Subject is nested within Seq.

Drug+Disease+(Drug*Disease) is not a valid use of parentheses in the model specifi­cation.

The weights for each record must be included in a separate column in the dataset.

Weight variables are used to compensate for observations having different variances.

When a weight variable is specified, each row of data is multiplied by the square root of the corresponding weight.

Weight variable values should be proportional to the reciprocals of the variances. Typically, the data are averages and weights are sample sizes associated with the averages.

The Weight variable cannot be a classification variable. It must be declared as a regressor/covariate before it can be used as a weight variable. It can also be used in the model.

None 

Ln(x): Linear transformation

Log10(x): Logarithmic base 10 transformation

Already Ln-transformed: Select if the dependent variable values are already transformed.

Already Log10-transformed: Select if the dependent variable values are already trans­formed.

Ln(x): Linear transformation

Already Ln-transformed: Select if the dependent variable values are already transformed.

Variance Structure tab

The Variance Structure tab allows users to set random effects and repeated specification for the bio­equivalence model. Users can also set traditional variance components and random coefficients. The Variance Structure tab is only available for average bioequivalence models.

bioeq00227.png 

Users can specify none, one, or multiple random effects. The random effects specify Z and the corre­sponding elements of G=Var(g). Users can specify only one repeated effect. The repeated effect specifies the R=Var(e).

Phoenix automatically specifies random effects models and repeated specifications for average bio­equivalence models. For more on the default models and specifications, see “Recommended models for average bioequivalence”.

The random effects model can be created using the classification variables.

Use the pointer to drag the variables from the Classification Variables box to Random 1 tab.

Users can also type variable names in the fields in the Random 1 tab.

The random effects model can be created using the regressor or covariate variables.

Use the pointer to drag the variables from the Regressors/Covariates box to Random 1 tab.

Users can also type variable names in the fields in the Random 1 tab.

Random 1 and Repeated tabs

The Random 1 tab is used to add random effects to the model. The random effects are built using the classification variables, the regressors/covariates variables, and the operator buttons.

The Repeated tab is used to specify the R matrix in the mixed model. If no repeated statement is specified, R is assumed to be equal to s2I. The repeated effect must contain only classification vari­ables.

The default repeated model depends on whether the crossover study is replicated or not.

Caution:The same variable cannot be used in both the fixed effects specification and the random effects specification unless it is used differently, such as part of a product. The same term (single vari­ables, products, or nested variables) must not appear in both specifications.

Variance Components 

Unstructured 

Banded Unstructured (b), type the number of bands in the Number of bands(b) field (default is 1)

Compound Symmetry 

Heterogeneous Compound Symmetry 

Autoregressive 

Heterogeneous Autoregressive 

No-Diagonal Factor Analytic 

Banded No-Diagonal Factor Analytic (f), type the number of factors in the Number of fac­tors (f) field (default is 1)

Toeplitz 

Banded Toeplitz (b), type the number of bands in the Number of bands(b) field (default is 1)

The number of factors or bands corresponds to the dimension parameter. For some covariance structure types this is the number of bands and for others it is the number of factors. For explana­tions of covariance structure types, see “Covariance structure types”.

Options tab

Settings in the Options tab change depending on whether the model type is average or population/individual.

Bioeq_Options_tab.png 

Bioequivalence Options tab

Average bioequivalence options

For more on the Anderson-Hauck test, see “Anderson-Hauck test”.

Population/Individual bioequivalence options

General Options tab

The General Options tab is used to set output and calculation options for a bioequivalence model. The options change depending on whether the model is average bioequivalence or population/individ­ual bioequivalence.

Bioeq_General_Options_tab.png 

Bioequivalence General Options tab

Average bioequivalence options

Residual: The same as the calculation method used in a purely fixed effects model.

Satterthwaite: The default setting and computes the df base on C2 approximation to distribu­tion of variance.

not estimable

0 (zero)

Note:The Generate initial variance parameters option is available only if the model uses random effects.

Highlight the row(s).

Select Edit >> Delete from the menubar or press X in the main toolbar.

Click the Selected Row(s) option button and click OK.

Population/Individual bioequivalence options

 


Last modified date:6/26/19
Certara USA, Inc.
Legal Notice | Contact Certara
© 2019 Certara USA, Inc. All rights reserved.